Geron | GERN - Pre Tax Profit

Stock Price
1.73
Daily Change
0.02 0.88%
Monthly
5.83%
Yearly
32.69%
Q2 Forecast
1.61

Geron reported $-31.14M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Amgen USD 3.92B 2.35B Sep/2025
Bio Techne USD 84.99M 107.85M Sep/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Exelixis USD 252.69M 275K Dec/2025
Genmab DKK 55M 427M Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Novavax USD 17.9M 220.94M Dec/2025